Global Health Assistance for Chronic Illness: A Look at the Practical

Progress in Cardiovascular Diseases

Volumn 51, Issue 1, 2008, Pages 89-96

  Greenberg, Henry ^a,b,c   Raymond, Susan U ^a,b,c   Leeder, Stephen R ^a,b,c  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC DISEASE; COMMERCIAL PHENOMENA; DIABETES MELLITUS; ECONOMIC ASPECT; HEALTH CARE DELIVERY; HEALTH PROMOTION; HEART DISEASE; PRIMARY MEDICAL CARE; PUBLIC HEALTH;

CHRONIC DISEASE; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; HEALTH TRANSITION; HUMANS;

EID: 47049109935     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2007.11.006     Document Type: Article

References (29)

1. WHO. Preventing chronic disease: a vital investment (2005), World Health Organization, Geneva
2. Omran A.R. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Q 49 (1971) 509-538
3. Murray C.J.L., and Lopez A.D. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349 (1997) 1269-1276
4. Leeder S., Raymond S., and Greenberg H. A Race against Time (2004), Earth Institute, Columbia University, New York
5. Yusuf S., Hawken S., Ounpuu S., et al. Effects of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case control study. Lancet 364 (2004) 937-952
6. Raymond S.U. Foreign assistance in an aging world. Foreign Aff 82 (2003) 91-105
7. Yusuf S., Reddy S., Ounpuu S., et al. Global burden of cardiovascular diseases: Part 1: general consideration, the epidemiologic transition, risk factors, and the impact of urbanization. Circulation 104 (2001) 2746-2753
8. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: 1. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 213 (1970) 1143-1151
9. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. 1. Reduction in mortality in persons with high blood pressure, including mild hypertension. JAMA 242 (1979) 2562-2571
10. Canner P.L., Berger K.G., Wenger N., et al. Fifteen year mortality in coronary drug program patients: long term benefit with niacin. J Am Coll Cardiol 8 (1986) 1245-1255
11. Lightwood J.M., and Glantz S.A. Short-term economic and health benefits of smoking cessation. Circulation 96 (1997) 1089-1096
12. Omenn G.S., Anderson K.W., Kronmal R.A., et al. The temporal pattern of reduction of mortality after smoking cessation. Am J Prev Med 6 (1990) 251-257
13. In: Murray C.J.L., and Lopez A.D. (Eds). The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 (1966), Harvard University Press, Cambridge
14. Murray C.J.L., and Lopez A.D. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: Global Burden of Disease Study. Lancet 349 (1997) 1347-1352
15. Murray C.J.L., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349 (1997) 1498-1504
16. Greenberg H., Raymond S.U., and Leeder S.R. Cardiovascular disease and global health: threat and opportunity. Health Affairs (2005) W5-W31 Web exclusive
17. Raymond S.U., Greenberg H., and Leeder S.R. Civil society confronts the challenge of chronic illness. Development 47 (2004) 97-103
18. Cleland C.F., Linehan M., and Adams L.V. Evaluation of development impact of USAID/AIHA's health partnership program in Central Asia and Eastern Europe. USAID (2006)
19. Farquhar J.W., Fortmann S.P., Flora J.A., et al. Effects of communitywide education on cardiovascular risk factors. The Stanford Five-City Project. JAMA 364 (1990) 359-365
20. Luepker R.V., Murray D.M., Jacobs D.R., et al. Community education for cardiovascular disease prevention: risk factor change in the Minnesota Health Program. Am J Public Health 84 (1994) 1383-1393
21. Community Intervention Trail for Smoking Cessation (COMMIT) 1. Cohort results from a four year intervention. Am J Public Health 85 (1995) 183-192
22. Ebrahim S., and Smith G.D. Exporting failure? Coronary heart disease and stroke in developing countries. Int J Epidemiol 30 (2001) 201-205
23. Pierce J.P., Macaskill P., and Hill D. Long term effectiveness of mass media led anti-smoking campaigns in Australia. Am J Public Health 80 (1990) 565-569
24. Rocella E.J., and Lenfant C. Considerations regarding the cost and effectiveness of public and patient education programs. J Hum Hypertens 6 (1992) 463-467
25. Hornik R.C. Introduction: public health communication: Making sense of contradictory evidence. In: Hornik R.C. (Ed). Public health communication evidence for behavior change (2002), Lawrence Erlbaum Associates, Mahwah, NJ 1-19
26. Burros M., and Warner M. Bottlers agree to a school ban on sweet drinks. N Y Times (2006) A-1
27. WHO. Report of the Commission on Macroeconomics and Health: investing in health for economic development (2001), World Health Organization, Geneva
28. Wang L., Kong L., Wu F., et al. Preventing chronic disease in China. Lancet 366 (2005) 1821-1824
29. Afghanistan: Measles vaccination campaign launched. IRIN news.org: 2 January 2002, www.irinnews.org/report.asp?ReportID=18290&SelectRegion=Central_Asia &Select. (Last accessed 2 October 2007)